LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Alkion BioInnovations

Similar companies to Alkion BioInnovations

Alkion BioInnovations Tech Stack

Alkion BioInnovations uses 8 technology products and services including WordPress, RequireJS, Hammer.js, and more. Explore Alkion BioInnovations's tech stack below.

  • WordPress
    Content Management System
  • RequireJS
    Javascript Frameworks
  • Hammer.js
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • RSS
    Miscellaneous
  • MyWebsite
    Page Builders
  • WPML
    Web Platform Extensions
  • Apache
    Web Servers

Media & News

Alkion BioInnovations's Email Address Formats

Alkion BioInnovations uses at least 1 format(s):
Alkion BioInnovations Email FormatsExamplePercentage
First.Last@alkinnov.comJohn.Doe@alkinnov.com
50%
First.Last@alkinnov.comJohn.Doe@alkinnov.com
50%

Frequently Asked Questions

Where is Alkion BioInnovations's headquarters located?

Minus sign iconPlus sign icon
Alkion BioInnovations's main headquarters is located at Route de Saint-Cyr Inra Center Versailles, Ile-de-France 78000 FR. The company has employees across 1 continents, including Europe.

What is Alkion BioInnovations's official website and social media links?

Minus sign iconPlus sign icon
Alkion BioInnovations's official website is alkinnov.com and has social profiles on LinkedIn.

What is Alkion BioInnovations's SIC code NAICS code?

Minus sign iconPlus sign icon
Alkion BioInnovations's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Alkion BioInnovations have currently?

Minus sign iconPlus sign icon
As of May 2024, Alkion BioInnovations has approximately 12 employees across 1 continents, including Europe. Key team members include Chief Scientific Officer: J. S.Ceo / Co-Founder: S. B.Managing Director/Cto: F. Y. P.. Explore Alkion BioInnovations's employee directory with LeadIQ.

What industry does Alkion BioInnovations belong to?

Minus sign iconPlus sign icon
Alkion BioInnovations operates in the Biotechnology Research industry.

What technology does Alkion BioInnovations use?

Minus sign iconPlus sign icon
Alkion BioInnovations's tech stack includes WordPressRequireJSHammer.jsModernizrRSSMyWebsiteWPMLApache.

What is Alkion BioInnovations's email format?

Minus sign iconPlus sign icon
Alkion BioInnovations's email format typically follows the pattern of . Find more Alkion BioInnovations email formats with LeadIQ.

How much funding has Alkion BioInnovations raised to date?

Minus sign iconPlus sign icon
As of May 2024, Alkion BioInnovations has raised $2.7M in funding. The last funding round occurred on Jun 07, 2022 for $2.7M.

When was Alkion BioInnovations founded?

Minus sign iconPlus sign icon
Alkion BioInnovations was founded in 2017.
Alkion BioInnovations

Alkion BioInnovations

Biotechnology ResearchÎle-de-France, France11-50 Employees

Alkion BioInnovations is a pionnier & leader in plant tissue propagation and bioengineering technologies. We have developed and patented a bioproduction platform to obtain high value ingredients (APIs, complex extracts and recombinant proteins) from plant biomass for pharmaceutical & agri-food markets on global and impactful projects. 

Through a carbon-neutral approach and using a minimum of resources in optimised bioreactors, our method of production is sustainable, ultra-scalable and cost-efficient.

With our European partners, we develop AI robots to build the world's first industrial in-vitro bioproduction platform, that aims to be flexible and versatile.

Our proprietary project is the large-scale production of the super immunity boosters "QS" for their urgent need, especially in Global South. Derived from Quillaja saponaria tree, QS enhance vaccine efficacy against infectious diseases such as Malaria, TB, HIV, Shigella etc. but also degenerative disorders and certain cancers. Our mission is to revolutionize global vaccine access by providing up to 2 billion doses p.a. at low cost and while preserving biodiversity. We work in collaboration with worldwide NGOs and universities.

A secondary project is the industrial standardised production of cannabinoids, API and extracts, for the therapeutic market (CNS diseases such as Parkinson, MS, neuropathic pain). For this project Alkion owns the first historical R&D licence from French health authorities (2018). 

In agrifood, our biosynthesis lab focuses on a healthy sweet protein derived from an exotic plant. It has exceptional physico-chemical properties for industrial applications as healthy sugar alternative in food and pharma products. The project aims at helping farmers increase their revenues while meeting a massive demand.

Alkion is laureate of I-Lab, I-Nov, Plan de Relance, the European Innovation Council Accelerator and is a finalist of Zayed Sustainability Prize in Health category (COP28).

Section iconCompany Overview

Headquarters
Route de Saint-Cyr Inra Center Versailles, Ile-de-France 78000 FR
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $2.7M

    Alkion BioInnovations has raised a total of $2.7M of funding over 9 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $2.7M.

Section iconFunding & Financials

  • $2.7M

    Alkion BioInnovations has raised a total of $2.7M of funding over 9 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $2.7M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.